Physician profile
Rick Lawson
NPI 1689676504
$2,566.81
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $239 · 2021: $343 · 2022: $315 · 2023: $863 · 2024: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $517.66 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $415.20 | 2019-2024 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $307.29 | 2019-2021 | |
| Shionogi INC | $280.59 | 2022-2024 | Fetroja |
| Merck Sharp & Dohme LLC | $270.12 | 2019-2024 | Recarbrio, Zerbaxa, Dificid |
| Pfizer INC. | $171.24 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $159.49 | 2019-2024 | Xifaxan |
| Ucb, INC. | $83.07 | 2023-2024 | Briviact |
| Boston Scientific Corporation | $82.92 | 2022-2023 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.29 | 2022-2023 | Jardiance |
| Allergan, INC. | $35.88 | 2019 | |
| Abbvie INC. | $32.69 | 2023 | |
| Avita Medical Americas, LLC | $27.74 | 2023 | Recell |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.08 | 2021 | |
| Csl Behring | $24.55 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $21.50 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Novo Nordisk INC | $17.41 | 2023 | Ozempic, Rybelsus |
| Melinta Therapeutics, LLC | $16.13 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.48 | 2022 | |
| Philips North America LLC | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Lawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.